About this trial
The goal of this randomized controlled trial is to test whether executive attention unpacks the antidepressant effect of Baduanjin (a form of health qigong) in older adults.
The main questions it aims to answer are:
* Is Baduanjin an effective treatment to enhance executive attention in older adults with depressive symptoms? * Does Baduanjin work through enhanced executive attention to alleviate depressive symptoms in older adults? Researchers will compare Baduanjin with waitlist control. Participants will receive 12-week Baduanjin training (two sessions per week and 60 min per session).
Eligibility criteria
Qualifiers
have mild or severer levels of depressive symptoms, as indicated by Geriatric Depression Scale scores of 5 or above or Depression Anxiety and Stress Scale-21 depression subscale scores of 4 or above
self-identified as physically stable and without life-threatening diseases
be able to communicate in Cantonese or Mandarin.
Disqualifiers
(have a history of practicing or receiving training in any form of mind-body or regular exercises (including tai chi, yoga, and qigong or regular physical activity > 3 times/week) during the month prior to recruitment
have changed medications or the dose of medications prescribed for their health condition in the month prior to study enrollment
have a severe cognitive or language impairment, as indicated by a score of less than 21 on the Montreal Cognitive Assessment
receiving pharmacological treatment, electroconvulsive therapy, psychotherapy, or psychoeducation for any psychological or psychiatric condition upon the time of recruitment
Trial design
Treatments tested in this trial
- Health qigong training